Drug use and medication adherence among HIV-1 infected individuals

AIDS and Behavior

Volumn 11, Issue 2, 2007, Pages 185-194

  Hinkin, Charles H ^a,b   Barclay, Terry R ^a   Castellon, Steven A ^a,b   Levine, Andrew J ^a   Durvasula, Ramani S ^c   Marion, Sarah D ^d   Myers, Hector F ^e,f   Longshore, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d Point Loma University   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

AIDS; Cocaine; Drug use; HIV infection; Medication adherence; Methamphetamine

Indexed keywords

ANTIVIRUS AGENT; COCAINE; ILLICIT DRUG; METHAMPHETAMINE; NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEVICE; DRUG ABUSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; STATISTICAL SIGNIFICANCE; URINALYSIS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COCAINE; DRUG MONITORING; ELECTRONICS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; METHAMPHETAMINE; MIDDLE AGED; PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS;

EID: 33847282357     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-006-9152-0     Document Type: Article

References (58)

1. Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Change, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(18), 1417-1423.
2. Arnsten, J., Demas, P., Grant, R., Gourevitch, M., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377-381.
3. Berg, K. M., Demas, P. A., Howard, A. A., Schoenbaum, E. E., Gourevitch, M. N., & Arnsten, J. H. (2004). Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine, 19(11), 1111-1117.
4. Bangsberg, D. R., Bronstone, A., & Hofmann, R. (2002). A computer based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care, 14(1), 3-15.
5. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14(4), 357-366.
6. Burke, L. E. (2001). Electronic measurement. In Burke L. E., & Ockene I. S. (Eds.), Compliance in healthcare and research. Armonk, NY: Futura Publishing Company.
7. Burney, K. D., Krishnan, K., Ruffin, M. T., Zhang, D., & Brenner, D. E. (1996). Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Archives of Family Medicine, 5, 297-300.
8. Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., et al. (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.Psychiatry Research: Neuroimaging, 114(2), 65-79.
9. Chesney, M., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science & Medicine, 50, 1599-1605.
10. Chermack, S. T., Roll, J., Reilly, M., Davis, L., Kilaru, U., & Grabowski, J. (2000). Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug & Alcohol Dependence, 59(1), 43-49.
11. Colfax, G., & Shoptaw, S. (2005). The methamphetamine epidemic: Implications for HIV prevention and treatment. Current HIV/AIDS Reports, 2(4), 194-199.
12. Crisp, B. R., Williams, M., Timpson, S., & Ross, M. W. (2004). Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS and Behavior, 8(2), 199-206.
13. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160(14), 2101-2107.
14. Ehrman, R. N., Robbins, S. J., & Cornish, J. W. (1997). Comparing self-reported cocaine use with repeated urine tests in outpatient cocaine abusers. Experimental and Clinical Psychopharmacology, 5(2), 150-156.
15. Fendrich, M., Johnson, T. P., Wislar, J. S., Hubbell, A., & Spiehler, V. (2004). The utility of drug testing in epidemiological research: Results from a general population survey. Addiction, 99, 197-208.
16. Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E., & Lawrence, J. B. (2004). The concordance of self-report with other measures of medication adherence: A summary of the literature. Medical Care, 42(7), 649-652.
17. Garcia de Olalla, P., Knobel, H., Carmona, A., Gnelar, A., Lopez-Colmes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome, 30, 105-110.
18. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patient on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndrome, 23, 386-395.
19. Golin, C.E., Liu, H., Hays, H.D., Miller, L.G., Beck, C.K., Ickovics, J., et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756-765.
20. Gonzalez, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B.C., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76(2), 181-190.
21. Halkitis, P.N., Kutnick, A.H., & Slater, S. (2005). The social realities of adherence to protease inhibitor regimens: Substance use, health care and psychological states. Journal of Health Psychology, 10(4), 545-558.
22. Hinkin, C. H., Castellon, S. A., Atkinson, J. H., & Goodkin, K. (2001). Neuropsychiatric aspects of HIV infection among older adults. Journal of Clinical Epidemiology, 54(Suppl 1), S44-52.
23. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., et al. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944-1950.
24. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(1), S19-S25.
25. Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J., O'Shaughnessy, M. V., Schechter, M. T., et al. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. Journal of the American Medical Association, 279(6), 450-454.
26. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175-2182.
27. Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16(2), 199-211.
28. Kalichman, S. C., Ramachandran, B., & Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14, 267-273.
29. Kilpatrick, B., Howlett, M., Sedgwick, P., & Ghodse, A. H. (2000). Drug use, self report and urinalysis. Drug and Alcohol Dependence, 58, 111-116.
30. Kimmerling, M., Wagner, G., & Ghosh-Dastidar, B. (2003). Factors associated with accurate self-reported adherence to HIV antiretrovirals. International Journal of STD & AIDS, 14, 281-284. .
31. Letendre, S. L., Cherner, M., Ellis, R. J., Marquie-Beck, J., Gragg, B., Marcotte, T., et al. (2005). The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: Biological correlates of disease. AIDS, 19(Suppl 3), S72-S78.
32. Levine, A., Hardy, D., Miller, E., Castellon, S., Longshore, D., & Hinkin, C. (2006). The effect of recent stimulant use on sustained attention in HIV-infected adults. Journal of Clinical and Experimental Neuropsychology, 28, 29-42.
33. Levine, A., Hinkin, C, Marion, S., Keuning, A., Castellon, S., Lam, M., et al. (In press, 2006). Adherence to antiretroviral medications in HIV: Differences in data collected via self-report and electronic monitoring. Health Psychology..
34. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
35. Lu, N. T., Taylor, B. G., & Riley, K. J. (2001). The validity of adult arrestee self-reports of crack cocaine use. American Journal of Drug & Alcohol Abuse, 27(3), 399-419.
36. Matthews, W.C., Mar-Tang, M., Ballard, C., Colwell, B., Abulhosn, K., Noonan, C., et al. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care and STDs, 16(4), 157-172.
37. Mohammed, H., Kieltyka, L., Richardson-Alston, G., Magnus, M., Fawal, H., Vermund, S. H., et al. (2004). Adherence to HAART among HIV-infected persons in Rural Louisiana. AIDS Patient Care and STDs, 18(5), 289-296.
38. Murphy, E. L., Collier, A. C., Kalish, L. A., Assmann, S. F., Para, M. R., Flanigan, T. P., et al. (2001). Highly active antiretroviral therapy decreases mortality and morbidity in patient with advanced HIV disease. Annals of Internal Medicine, 135, 17-26.
39. Nieuwkerk, P. Y., Sprangers, M. A., Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., et al. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort. Archives of Internal Medicine, 161, 1962-1968.
40. O'Brien, M. K., Petrie, K., & Raeburn, J. (1992). Adherence to medication regimens: Updating a complex medical issue. Medical Care Review, 49, 435-454.
41. Ory, M. G., & Mack, K. A. (1998). Middle-aged and older people with AIDS. Research on Aging, 20, 653-664.
42. Palella, F. J. Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. New England Journal of Medicine, 338(13), 853-860.
43. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
44. Paterson, D., Potoski, B., & Capitano, B. (2002). Measurement of adherence to antiretroviral medications. JAIDS, 31, S103-S106.
45. Rabkin, J. G., & Chesney, M. (1999). Treatment adherence to HIV medications: The Achilles heel of the new therapeutics. In Ostrow D., Kalichman S. (Eds.), Behavioral and mental health impacts of new HIV therapies. New York: Plenum Press.
46. Reback, C. J., Larkins, S., & Shoptaw, S. (2003). Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care, 15(6), 775-785.
47. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1-14.
48. Sharpe, T.T., Lee, L.M., Nakashima, A.K., Elam-Evans, L.D., & Fleming, P.L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29(2), 117-27.
49. Simoni, J. M., Frick, P. A., & Huang, B. (2006). A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology, 25(1), 74-81.
50. Smith, M. Y., Rapkin, B. D., Morrison, A., & Kammerman, S. (1997). Zidovudine adherence in persons with AIDS: Relation of patient beliefs about medications to self-termination of therapy. Journal of General Internal Medicine, 12, 216-223.
51. Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M., B. (1992). The Structured Clinical Interview for DSM-III-R (SCID): I. History, rationale, and description. Archives of General Psychiatry, 49(8), 624-629.
52. Stein, M. D., Rich, J. D., Maksad, J., Chen, M. H., Hu, P., Sobota, M., et al. (2000). Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. American Journal of Drug and Alcohol Abuse, 26(2), 195-205.
53. Stephenson, B. J., Rowe, B. H., Haynes, R. B., Macharia, W. M., & Leon, G. (1993). Is this patient taking the treatment as prescribed? Journal of the American Medical Association, 269, 2779-2781.
54. Tassiopoulos, K. B., Bernstein, J., Heeren, T., Levenson, S., Hingson, R., & Bernstein, E. (2004). Hair testing and self report of cocaine use by heroin users. Addiction, 99(5), 590-597.
55. Tucker, J. S., Orlando, M., Burnam, M. A., Sherbourne, C. D., Kung, F., & Gifford, A. L. (2004). Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23(4), 363-370.
56. Volkow, N. D., Chang, L., Wang, G., Fowler, J. S., Leonido-Yee, M., Franceschi, D., et al. (2001). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158(3), 377-382.
57. Wainberg, M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977-1983.
58. Wohl, D., Stephenson, B., Golin, C., Kiziah, N., Rosen, D., Ngo, B., et al. (2003). Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clinical Infectious Diseases, 36, 1572-1576.